Hereditary Breast and Ovarian Cancer Clinical Trials

5 recruiting

Hereditary Breast and Ovarian Cancer Trials at a Glance

8 actively recruiting trials for hereditary breast and ovarian cancer are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Washington D.C., Bellinzona, and Berlin. Lead sponsors running hereditary breast and ovarian cancer studies include Georgetown University, Peking University Third Hospital, and OHSU Knight Cancer Institute.

Browse hereditary breast and ovarian cancer trials by phase

Treatments under study

About Hereditary Breast and Ovarian Cancer Clinical Trials

Looking for clinical trials for Hereditary Breast and Ovarian Cancer? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hereditary Breast and Ovarian Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hereditary Breast and Ovarian Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Familial Investigations of Childhood Cancer Predisposition

Hereditary Breast and Ovarian CancerHodgkin LymphomaAdrenocortical Carcinoma+30 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting
Not Applicable

Identifying and Caring for Individuals With Inherited Cancer Syndrome

BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
OHSU Knight Cancer Institute27,500 enrolled2 locationsNCT04494945
Recruiting

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Breast CancerHereditary Breast and Ovarian Cancer
University of Kansas Medical Center1,500 enrolled11 locationsNCT02302742
Recruiting
Not Applicable

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Breast Neoplasm FemaleHereditary Breast and Ovarian Cancer SyndromeEarly Detection of Cancer+1 more
Georgetown University80 enrolled1 locationNCT06892275
Recruiting
Not Applicable

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

Hereditary Breast and Ovarian Cancer
Georgetown University332 enrolled2 locationsNCT05130606
Recruiting

Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

Hereditary Breast and Ovarian Cancer SyndromeBRCA Mutations
Peking University Third Hospital10,000 enrolled1 locationNCT07039552
Recruiting

Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

Hereditary Breast and Ovarian CancerLynch Syndrome
University of Basel700 enrolled9 locationsNCT03124212
Recruiting
Not Applicable

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Hereditary Breast and Ovarian Cancer
Technical University of Munich600 enrolled19 locationsNCT02516540